The Patent Finder

Terms ending in 2039

Fondation Imagine

Every in-force patent on Fondation Imagine's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,257,232Methods and Pharmaceutical Compositions for the Treatment of FGFR3-RELATED Chondrodysplasias
In force
 · High confidence
Inserm (Institut National de la Sante et de la Recherche Medicale), Universite de Paris, Fondation Imagine, Assistance Publique-Hopitaux de Paris (Aphp) and Universidad de GranadaIn forceHigh confidence
US 11,473,145Methods for Determining Whether a Patient Suffering from Rhabdomyolysis Achieves a Response with a TLR9 Antagonist
In force
 · Medium confidence
Université Paris CitéIn forceMedium confidence
US 12,778,952Infigratinib for Treatment of FGFR3-RELATED Skeletal Diseases During Pregnancy
In force
 · High confidence
Assistance Publique-Hôpitaux de Paris (Aphp)In forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Fondation Imagine.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited